<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03250338</url>
  </required_header>
  <id_info>
    <org_study_id>ARO-013</org_study_id>
    <secondary_id>2017-001600-29</secondary_id>
    <nct_id>NCT03250338</nct_id>
  </id_info>
  <brief_title>Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML</brief_title>
  <official_title>Phase III Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of the Addition of Crenolanib to Salvage Chemotherapy Versus Salvage Chemotherapy Alone in Subjects ≤ 75 Years of Age With Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arog Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arog Pharmaceuticals, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, multi-center, double-blind, placebo-controlled study designed to
      evaluate the efficacy of crenolanib administered following salvage chemotherapy,
      consolidation chemotherapy, post bone marrow transplantation and as maintenance in
      relapsed/refractory AML subjects with FLT3 activating mutation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 5, 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Event-free survival (EFS)</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free Survival (RFS)</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete remission rate (CR)</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRD negative complete remission rate</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">322</enrollment>
  <condition>Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations</condition>
  <arm_group>
    <arm_group_label>Crenolanib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Crenolanib following salvage chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo following salvage chemotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crenolanib</intervention_name>
    <description>Crenolanib will be administered orally</description>
    <arm_group_label>Crenolanib</arm_group_label>
    <other_name>Crenolanib besylate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cytarabine</intervention_name>
    <description>HAM regimen
FLAG-Ida</description>
    <arm_group_label>Crenolanib</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mitoxantrone</intervention_name>
    <description>HAM regimen</description>
    <arm_group_label>Crenolanib</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Tablet</intervention_name>
    <description>Placebo will be administered orally</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fludarabine</intervention_name>
    <description>FLAG-Ida regimen</description>
    <arm_group_label>Crenolanib</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Idarubicin</intervention_name>
    <description>FLAG-Ida regimen</description>
    <arm_group_label>Crenolanib</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>G-CSF</intervention_name>
    <description>FLAG-Ida regimen</description>
    <arm_group_label>Crenolanib</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed diagnosis of AML according to World Health Organization (WHO) 2016
             classification

          2. Presence of FLT3-ITD and/or D835 mutation(s)

          3. Subjects must be primary refractory or relapsed to 1st line intensive treatment for
             AML or refractory or relapsed after second line of treatment for AML

          4. Age ≥ 18 years and ≤ 75 years

          5. Adequate hepatic function

          6. Adequate renal functions

          7. ECOG performance status ≤ 3

        Exclusion Criteria:

          1. Known clinically active central nervous system(CNS) leukemia

          2. Severe liver disease

          3. Known, active infection with hepatitis B virus (HBV) or hepatitis C virus (HCV)

          4. Prior anti-leukemia therapy within the 14 days prior to randomization. Prior use of
             quizartinib or gilteritinib must be discontinued 21 days prior to randomization. Prior
             use of hydroxyurea or other palliative treatment for leukocytosis is allowed.

          5. Previous treatment with crenolanib or prior participation in clinical trial involving
             crenolanib.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eunice Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roswell Park Cancer Institute, Buffalo, New York, United States, 14263</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>General Contact</last_name>
    <phone>214-593-0500</phone>
    <email>info@arogpharma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>City of Hope National Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chatchada Karanes, MD</last_name>
      <phone>626-218-2405</phone>
      <email>CKaranes@coh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UC Davis Comprehensive Cancer Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Jonas, MD</last_name>
      <phone>916-734-5959</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jack Hsu, MD</last_name>
      <phone>352-273-7832</phone>
      <email>jack.hsu@medicine.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongtao Liu, MD</last_name>
      <email>hliu@medicine.bsd.uchicago.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas University</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>666160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunil Abhyankar, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sunil Abhyankar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karmanos Cancer Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Yang, MD</last_name>
      <email>yangj@karmanos.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yue Guo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yue Guo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eunice Wang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Eunice Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rupali Bhave, MD</last_name>
      <phone>336-716-5487</phone>
      <email>rbhave@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2R3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Brandwein, M.D.</last_name>
      <phone>780-407-7482</phone>
      <email>jbrandwe@ualberta.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <zip>93000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorsten Braun, MD</last_name>
      <phone>+33(0)-1-48-95-75-05</phone>
      <email>Thorsten.braun@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble Alpes</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Yves Cahn, MD</last_name>
      <email>JYCahn@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Center of Versailles (Le Chesnay)</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78157</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Rousselot, MD</last_name>
      <phone>+33 (0)1.39.63.86.22</phone>
      <email>phrousselot@ch-versailles.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Claude Huriez - Chru Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Quesnel, MD</last_name>
      <phone>+33 (0)3 20 44 66 40</phone>
      <email>bruno.quesnel@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Paoli-Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Vey, MD</last_name>
      <phone>+33491223754</phone>
      <email>veyn@ipc.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes - Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Peterlin, MD</last_name>
      <phone>+33(0)2.44.76.84.45</phone>
      <email>Pierre.peterlin@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Nice L'Archet</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Cluzeau</last_name>
      <phone>+33(0) 492 035 839</phone>
      <email>cluzeau.thomas@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital St Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Raffoux, MD</last_name>
      <phone>01 42 49 96 49</phone>
      <email>emmanuel.raffoux@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud Pigneux, MD</last_name>
    </contact>
    <contact_backup>
      <phone>+ 33 5 57 65 65 11</phone>
      <email>arnaud.pigneux@chu-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69494</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Thomas, MD</last_name>
      <phone>+33 47886 2240</phone>
      <email>xavier.thomas@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria-Pilar Gallego-Hernanz, MD</last_name>
      <phone>+33 (0)5.49.44.30.29</phone>
      <email>Maria-Pilar.Gallego-Hernanz@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire du Cancer Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Recher, MD</last_name>
      <phone>+33 0531156355</phone>
      <email>Recher.christian@iuct-oncopole.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <zip>09116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias Hänel, MD</last_name>
      <phone>+49 371 333 44500</phone>
      <email>m.haenel@skc.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Technische Universität Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Rollig, MD</last_name>
      <email>Christoph.Roellig@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen (AöR)</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Noppeney, MD</last_name>
      <phone>+49 201 723-84706</phone>
      <email>Richard.noppeney@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bjorn Steffen, MD</last_name>
      <phone>+49 69 6301 83654</phone>
      <email>steffen@em.uni-frankfurt.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Halle (Saale)</name>
      <address>
        <city>Halle</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haifa Kathrin Al-Ali, MD</last_name>
      <phone>+49 345 557 4909</phone>
      <email>haifa.al-ali@uk-halle.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan-Henrik Mikesch, MD</last_name>
      <phone>+49 251 835 2818</phone>
      <email>Jan-Henrik.Mikesch@ukmuenster.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Tor Vergata</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriano Venditti, MD</last_name>
      <phone>+39 0620903226</phone>
      <email>adriano.venditti@uniroma2.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Policlinico Sant'Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Curti, MD</last_name>
      <phone>+39 051 2144074</phone>
      <email>antonio.curti2@unibo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASST Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara Cattaneo, MD</last_name>
      <phone>+39 030 3996269/6416</phone>
      <email>chiara.cattaneo@asst-spedalicivili.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Bosi, MD</last_name>
      <phone>+39 0557947476</phone>
      <email>alberto.bosi@unifi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRST - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori</name>
      <address>
        <city>Meldola</city>
        <zip>47014</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Mertinelli, MD</last_name>
      <phone>+39 0543739480</phone>
      <email>giovanni.martinelli@irst.emr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Foundation Ca 'Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Fracchiolla, MD</last_name>
      <email>nicola.fracchiolla@policlinico.mi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Europeo di Oncologia</name>
      <address>
        <city>Milano</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabetta Todisco, MD</last_name>
      <phone>+39 0294372920</phone>
      <email>elisabetta.todisco@ieo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio Ciceri, MD</last_name>
      <phone>+39 0226434289</phone>
      <email>ciceri.fabio@hsr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aorn Antonio Cardarelli</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felicetto Ferrara, MD</last_name>
      <phone>0039-0817472241</phone>
      <email>felicetto.ferrara@aocardarelli.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Federico II</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrizio Pane, MD</last_name>
      <phone>+39 0817462037</phone>
      <email>fabrizio.pane@unina.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Maggiore della Carità</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monia Lunghi, MD</last_name>
      <phone>+39 0321 3732194</phone>
      <email>monia.lunghi@med.uniupo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AO Ospedali Riuniti Marche Nord</name>
      <address>
        <city>Pesaro</city>
        <zip>61122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Visani, MD</last_name>
      <phone>+39 0721364039</phone>
      <email>giuseppe.visani@ospedalimarchenord.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria delle Croci di Ravenna</name>
      <address>
        <city>Ravenna</city>
        <zip>48121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Lanza, MD</last_name>
      <phone>+39 0544285752</phone>
      <email>francesco.lanza@auslromagna.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario Agostino Gemelli</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrizia Chiusolo, MD</last_name>
      <phone>+39(0)630154968</phone>
      <email>patrizia.chiusolo@unicatt.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Città della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano D'Ardia, MD</last_name>
      <phone>+39 0116335611</phone>
      <email>sdardia@cittadellasalute.to.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AO Ordine Mauriziano di Torino</name>
      <address>
        <city>Torino</city>
        <zip>10128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Saglio, MD</last_name>
      <phone>+39 0115082175</phone>
      <email>giuseppe.saglio@unito.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico GB Rossi, University Hospital Verona</name>
      <address>
        <city>Verona</city>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianpaolo Nadali, MD</last_name>
      <phone>+39-(0)45-8124420</phone>
      <email>gianpaolo.nadali@univr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AULSS n 8 Berica Ospedale San Bortolo</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eros Di Bona, MD</last_name>
      <phone>+39-0444-753518</phone>
      <email>eros.dibona@aulss8.veneto.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital U. Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <state>Andalucia</state>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Antonio Perez Simon, MD</last_name>
      <phone>34 95 501 3273</phone>
      <email>josea.perez.simon.sspa@juntadeandalucia.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias (HUCA)</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Bernal del Castillo, MD</last_name>
      <phone>00 34 618 75 39 04</phone>
      <email>bernaldelcastillo@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario A Coruna</name>
      <address>
        <city>A Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Noriega Concepcion, MD</last_name>
      <phone>34 981178055</phone>
      <email>victor.noriega.concepcion@sergas.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Pedro de Alcantara Hospital</name>
      <address>
        <city>Cáceres</city>
        <zip>10003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Bergua Bergues, MD</last_name>
      <phone>+34 927 62 15 40</phone>
      <email>jmberguaburg@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Reina Sofia University Hospital</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josefina Serrano Lopez, MD</last_name>
      <phone>+ 34 607680781</phone>
      <email>josefina.serrano@iname.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Donostia</name>
      <address>
        <city>Donostia San Sebastian</city>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esther P Santaolalla, MD</last_name>
      <phone>+34 943 00 75 72</phone>
      <email>esther.perezsantaolalla@osakidetza.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Herrera Puente, MD</last_name>
      <phone>34 91 336 8967</phone>
      <email>pherrera.hrc@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Lopez, MD</last_name>
      <phone>+34 622284472</phone>
      <email>JLLopez@quironsalud.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Calbacho Robles, MD</last_name>
      <phone>34 91 390 8652</phone>
      <email>mcalbachorobles@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene S Vadillo, MD</last_name>
      <phone>+34 912071247</phone>
      <email>Irene.sanchezv@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Maranon Servicio de Hematologia y Hemoterapia</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Monsalvo, MD</last_name>
      <phone>+34 915868396</phone>
      <email>silvia.monsalvo@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belen Vidriales, MD</last_name>
      <phone>+34923291100</phone>
      <phone_ext>55375</phone_ext>
      <email>mbvidriales@saludcastillayleon.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital U. Marques de Valdecilla</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Colorado Araujo, MD</last_name>
      <phone>34 94 220 2520</phone>
      <email>mcolorado@humv.es; mercedes.colorado@scsalud.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Santiago</name>
      <address>
        <city>Santiago De Compostela</city>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia A Vence, MD</last_name>
      <phone>+34 981950172</phone>
      <email>natalia.alonso.vence@sergas.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politecnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pau Montesinos, MD</last_name>
      <phone>+34 961244000</phone>
      <email>montesinos_pau@gva.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 11, 2017</study_first_submitted>
  <study_first_submitted_qc>August 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cytarabine</mesh_term>
    <mesh_term>Fludarabine</mesh_term>
    <mesh_term>Mitoxantrone</mesh_term>
    <mesh_term>Idarubicin</mesh_term>
    <mesh_term>Crenolanib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

